Patients with newly diagnosed advanced ovarian cancer have a marked increase in progression-free survival with maintenance olaparib after successful first-line chemotherapy, phase 3 study data indicates.
Medscape Medical News
Original Article: 'Outstanding' Ovarian Cancer PFS With Olaparib Maintenance